✦ LIBER ✦

PDB63 ESTIMATING THE LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN ASPART (NOVORAPID®) FROM HUMAN SOLUBLE INSULIN IN TYPE 2 DIABETES PATIENTS IN THE POLISH SETTING

✍ Scribed by K Erny-Albrecht; G Goodall; S Nielsen; C Townsend; R Kotchie; WJ Valentine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB47 LONG-TERM ECONOMIC OUTCOMES ASSOCI

✍ WJ Valentine; G Goodall; C Townsend; R Kotchie; S Nielsen; K Erny-Albrecht 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

ED2 LONG-TERM COST-UTILITY ANALYSIS OF I

✍ G Goodall; WJ Valentine; C Townsend; R Kotchie; S Nielsen; K Erny-Albrecht 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PDB22 EVALUATING THE LONG-TERM COST-EFFE

✍ K Erny-Albrecht; G Goodall; C Townsend; R Kotchie; S Nielsen; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB10 LONG-TERM CLINICAL AND ECONOMIC OU

✍ D Tucker; AS Brandt; V Foos; V Munro; G Goodall; J Ray; WJ Valentine; S Roze; AJ 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PDB22 LONG-TERM COST-EFFECTIVENESS OF IN

✍ ME Minshall; NS Twena; L Nicklasson; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PDB24 LONG-TERM CLINICAL AND COST OUTCOM

✍ JP Clegg; WJ Valentine; K Rychna; M Honka; T Dolezal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB